Bevacizumab in the treatment of solid tumors
Prof. MUDr. Jindřich Fínek, Ph.D., MHA
Onkologická a radioterapeutická klinika LF UK a FN, Plzeň
Bevacizumab is a universal anti-VEGF drug effective in numerous solid tumors in combination with chemotherapy.
breast carcinoma, ovarian cancer, chemotherapy, targeted treatment
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...